Nath Bio-Genes (India) Limited (NATHBIOGEN) Financial Results — Revenue ₹4,316 Cr

Revenue: ₹4,316 CrNet Profit: ₹384 Cr

📢 Key Event
Nath Bio-Genes reported FY26 revenue of ₹4,316 crores, up 19% YoY, with cotton and maize driving growth.

🔄 What Changed
Revenue grew 19% YoY to ₹4,316 crores; cotton value growth (+28%) and maize volume growth (+54%) were key drivers; gross margin declined to 56% from 63%; EBITDA margin stable at 12%; Uzbekistan contributed ₹15 crores to revenue for the first time.

🔮 What's Next
The company highlighted plans to expand international markets, particularly Uzbekistan, and maintain focus on R&D, supply chain efficiency, and product innovation to sustain growth and margin expansion.

💡 Investor Takeaway
Investors should note strong growth in cotton and maize offsetting vegetable seed declines, with international revenue emerging as a new growth vector, though gross margin pressure warrants monitoring of cost management.

Nath Bio-Genes reported FY26 revenue of ₹4,316 crores, up 19% YoY, driven by cotton (+28% value growth) and maize (+78% growth), though vegetable seeds declined 15%. Cotton now represents 29% of revenue, while paddy holds 29% and others 42%. Gross margin fell to 56% from 63%, but EBITDA margin held steady at 12% despite a 7% YoY revenue dip in Q4. International expansion reached a milestone with Uzbekistan contributing ₹15 crores to revenue. The company emphasized R&D investment, supply chain strength, and farmer-centric innovation to sustain growth.

📄 View Original Announcement (PDF)

📊 Stock Analysis — NATHBIOGEN ✨ Ask AI About This